Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H36N4O6 |
InChIKeyYMTZZJOPSATRTO-GOTSBHOMSA-N |
CAS Registry1595275-71-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | - |